Find

The MR Research Centre

Jørgen Frøkiær

Pilot Study Experiences With Hyperpolarized [1-¹³C]pyruvate MRI in Pancreatic Cancer Patients

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Comment/debate/letter to the editor › Research › peer-review

DOI

https://doi.org/10.1002/jmri.26888
Final published version

Hans Stødkilde-Jørgensen
Christoffer Laustsen
Esben Søvsø Szocska Hansen
Rolf Schulte, General Electric Healthcare, Munich, Germany.
Jan Henrik Ardenkjaer-Larsen, General Electric Healthcare, Brøndby, Denmark., Biomedical Engineering, DTU Elektro, Technical University of Denmark, Kongens Lyngby, Denmark., Denmark
Arnaud Comment, General Electric Healthcare, Chalfont St Giles, UK.
Jørgen Frøkiaer
Steffen Ringgaard
Lotte Bonde Bertelsen
Morten Ladekarl
Britta Weber, Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark.

Level of Evidence: 5. Technical Efficacy Stage: 1.

Original language	English
Journal	Journal of Magnetic Resonance Imaging
Volume	51
Issue	3
Pages (from-to)	961-963
Number of pages	3
ISSN	1053-1807
DOIs	https://doi.org/10.1002/jmri.26888
Publication status	Published - 1 Mar 2020

See relations at Aarhus University Citationformats

ID: 160768505

The MR Research Centre

mr.au.dk

Jørgen Frøkiær

Pilot Study Experiences With Hyperpolarized [1-13C]pyruvate MRI in Pancreatic Cancer Patients

DOI

Pilot Study Experiences With Hyperpolarized [1-¹³C]pyruvate MRI in Pancreatic Cancer Patients